tirzepatide news today recency 3 Endocrinology Obesity articles page [12] Zepbound beats Wegovy for weight

Your doctor should assess several factors before approving discontinuation, including your current weight status and trajectory, the presence and control of obesity-related comorbidities (type 2 diabetes, hypertension, sleep apnea, cardiovascular disease), your readiness and capacity to implement intensive lifestyle modifications, available support systems and resources, and your history of weight cycling or previous weight loss attempts

The PD-1/VEGF bispecific showed superior PFS against Keytruda in a head-to-head trial in PD-L1+ patients

Monitoring & Adjustments Providers monitor your progress and adjust your treatment plan as needed, while offering guidance on nutrition, exercise, and sustainable habit-building

You no longer have to obsess over every single calorie

The sharp decline usually associated with aging flattens out